# CareTrust REIT, Inc. (CTRE)

> Source: Nexqual · https://nexqual.com/CTRE · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, CareTrust REIT, Inc. (CTRE), nexqual.com/CTRE" · informational, not investment advice.

**Price:** USD 36.62 (+2.72% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 35.65 · day 35.66–36.73 · 52w 33.72–43.62 · market cap $8.65B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $571M, net income $355M (62.2% margin) (SEC filings).
- Valuation: P/E 24.3x (avg 33.6x at the last 3 fiscal year-ends), net debt $1.16B.
- Analysts: Buy (mean 2.00 on a 1–5 scale) (14 analysts), mean target USD 43.64 (range 41–49).
- Total return with dividends: 1Y +9.1% vs S&P 500 +14.9%; 5Y +118.8% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 0.43, revenue estimate $159M.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $192M | $196M | $218M | $296M | $476M | $571M |
| Gross profit | $192M | — | — | — | — | — |
| Net income | $72.0M | -$7.5M | $53.7M | $125M | $321M | $355M |
| EPS (diluted) | $0.74 | -$0.08 | $0.50 | $0.80 | $1.57 | — |
| Gross margin | 100.0% | — | — | — | — | — |
| Net margin | 37.4% | -3.8% | 24.7% | 42.2% | 67.3% | 62.2% |
| Revenue growth | +7.9% | +2.0% | +11.0% | +36.1% | +60.8% | — |
| Cash + short-term investments | $19.9M | $13.2M | $294M | $214M | $198M | — |
| Total debt | $673M | $719M | $596M | $397M | $894M | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 24.3x · P/S 15.1x · EV/Sales 17.2x · P/B 1.9x · Earnings yield 4.11% · Dividend yield (paid, TTM) 3.53% · Net debt $1.16B · EV $9.81B
P/E at fiscal year-ends: Dec 2025 23.0x, Dec 2024 33.6x, Dec 2023 44.2x.

## Analysts
Consensus Buy (mean 2.00 on a 1–5 scale), 14 analysts; mean target USD 43.64 (low 41, high 49).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Wells Fargo | Target lowered | Overweight | $44 → $43 |
| 2026-10-16 | JP Morgan | Initiated | Neutral | $41 |
| 2026-10-13 | UBS | Target lowered | Buy | $48 → $44 |
| 2026-10-05 | Raymond James | Target lowered | Outperform | $45 → $42 |
| 2026-10-05 | RBC Capital | Reiterated | Sector Perform | $43 |
| 2026-10-05 | BMO Capital | Target lowered | Outperform | $47 → $45 |
| 2026-09-01 | Wells Fargo | Target lowered | Overweight | $47 → $44 |
| 2026-08-14 | RBC Capital | Downgrade | Outperform → Sector Perform | $44 → $43 |
| 2026-08-10 | Cantor Fitzgerald | Target raised | Neutral | $42 → $43 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +9.1% | +118.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +9.2% | +16.9% |
| Volatility (annualized) | 25.0% | 23.1% |
| Max drawdown | -17.0% (Jul 2026→Oct 2026) | -28.7% (Jan 2022→Apr 2022) |

## Peers (REIT - Healthcare Facilities)
AHR (American Healthcare REIT, Inc.) USD 53.4 +1.02% · HR (Healthcare Realty Trust Incorpo) USD 17.93 +4.00% · DOC (Healthpeak Properties, Inc.) USD 19.34 +4.65% · OHI (Omega Healthcare Investors, Inc) USD 46.3 +4.16% · SBRA (Sabra Health Care REIT, Inc.) USD 19.6 +3.70% · NHI (National Health Investors, Inc.) USD 66.96 +3.14%

## More
Full page: https://nexqual.com/CTRE · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Customer concentration

Period ended 2026-06-30: 15% of revenue from unnamed direct customers (10-Q, filed 2026-08-06).

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.43 | $0.42 | +0.2% | $159.0M | 5 |
| Next quarter (ends 2026-12-31) | $0.44 | $0.43 | +2.3% | $180.3M | 4 |
| Current fiscal year (ends 2026-12-31) | $1.72 | $1.80 | -4.9% | $627.5M | 3 |
| Next fiscal year (ends 2027-12-31) | $1.88 | $1.74 | +7.7% | $823.7M | 4 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-11-05): ±6.3%; last 8 reports averaged ±2.3%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 26.3% | ±6.3% |
| 2026-12-18 | 56 | 24.2% | ±7.9% |
| 2027-01-15 | 84 | 24.7% | ±10.0% |
| 2027-04-16 | 175 | 25.8% | ±14.7% |